HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.

Abstract
REV 3164 has been evaluated in a variety of intact rodent models to reveal potential utility in the prophylactic treatment of asthma. REV 3164 was found a potent, orally active inhibitor of rat (IgE) passive cutaneous anaphylaxis (PCA, ED50 = 0.9 mg/kg). By contrast, at 50-200 mg/kg p.o., it did not affect guinea-pig (IgG1) PCA. In PCA rats, both REV 3164, 1-36 mg/kg i.p., and the known inhibitor of mast cell mediator release, disodium cromoglycate (DSCG), 2-54 mg/kg i.p., blocked cutaneous wheals caused by i.v. antigen challenge but not by intradermal serotonin or histamine. Neither REV 3164 (0.1-10 mg/kg i.p.) nor DSCG (2-54 mg/kg i.p.) affected Compound 48/80-induced wheals. REV 3164 (0.01-1 mg/kg i.v. or 10 mg/kg i.p.) abolished rat (IgE) passive lung anaphylaxis (PLA, ED50 = 0.05 mg/kg i.v. for inhibition of elevated airway resistance). At 10 mg/kg i.p., REV 3164 did not affect active lung anaphylaxis in guinea-pigs pharmacologically manipulated to enhance the production and action of slow reacting substance of anaphylaxis (SRS-A), nor did it exhibit anticholinergic activity in the rat. REV 3164 (100 mg/kg i.p.) did not protect conscious guinea-pigs from histamine aerosol-induced collapse. It is concluded that REV 3164 is an oral inhibitor of IgE-dependent immediate hypersensitivity in the rat with biological activities in rats and guinea-pigs similar to DSCG.
AuthorsM Leibowitz, R J Gordon, P S Wolf, P Sonnino-Goldman
JournalArchives internationales de pharmacodynamie et de therapie (Arch Int Pharmacodyn Ther) Vol. 271 Issue 1 Pg. 135-54 (Sep 1984) ISSN: 0003-9780 [Print] Belgium
PMID6497506 (Publication Type: Journal Article)
Chemical References
  • Histamine Antagonists
  • Immunoglobulin G
  • Parasympatholytics
  • Quinoxalines
  • SRS-A
  • Serotonin Antagonists
  • Triazoles
  • Immunoglobulin E
  • p-Methoxy-N-methylphenethylamine
  • 7-chloro-5-propyl-1,2,4-triazolo(4,3-a)quinoxaline-1,4(2H,5H)-dione
Topics
  • Animals
  • Antibody Formation (drug effects)
  • Asthma (physiopathology)
  • Bronchi (drug effects)
  • Guinea Pigs
  • Histamine Antagonists (pharmacology)
  • Immunoglobulin E (immunology)
  • Immunoglobulin G (immunology)
  • Male
  • Parasympatholytics (pharmacology)
  • Passive Cutaneous Anaphylaxis (drug effects)
  • Quinoxalines (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Respiratory System (drug effects)
  • SRS-A (physiology)
  • Serotonin Antagonists (pharmacology)
  • Species Specificity
  • Time Factors
  • Triazoles
  • p-Methoxy-N-methylphenethylamine (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: